CGAS and COVID-19: Cyclic GMP-AMP synthase (cGAS)–stimulator of interferon genes (STING) pathway controls immunity to cytosolic double-stranded (ds)DNA, driving aberrant type I IFN responses in COVID-19 patients (38–40).